SCM Pharma, a UK-based fill/finish provider, has launched two new testing services to complement its sterile manufacturing capabilities and reduce the risks associated with offsite testing for client projects. SCM has introduced Sterility and Bacterial Endotoxin Testing (BET) to its GMP-compliant facility, to supplement its existing analytical, stability and microbiological testing capabilities. Both methods are set to be rolled out for clients on a number of recently secured contracts by SCM...